- Mass spectrometer identifies pathogens directly in tissue and stool samples

- So far 232 medically important bacterial species detectable

- Database must now be further expanded

Speed and reliability are crucial in the diagnosis of diseases. Researchers at the Technical University of Munich (TUM) and Imperial College London have developed a new method to identify bacteria with unprecedented speed. This means that the waiting time can be reduced from several days to just a few minutes.

An intriguing editorial in the Psychedelics journal announces an expanded focus beyond traditional psychedelic compounds to include the full spectrum of consciousness-altering substances. Editor-in-Chief Dr. Julio Licinio frames this approach as part of humanity's ongoing quest to transcend our inherent incompleteness.

In a groundbreaking Genomic Press interview, Dr. Michael Wheeler of Harvard Medical School reveals how psychedelics like psilocybin can reverse stress-induced fear behaviors by modulating neuroimmune pathways. His recent Nature publication demonstrates that psychedelics reduce immune cell accumulation in brain meninges while simultaneously reducing fear behaviors, opening new therapeutic possibilities.